Other gastrointestinal effects that may occur on the first day or within the initial week include mild abdominal discomfort, bloating, or changes in bowel habits
Patil HR, Al Badarin FJ, Al Shami HA, Bhatti SK, Lavie CJ, Bell DS, OKeefe JH: Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus
The first GLP-1 analog, exenatide (Byetta), lowering blood pressure exerting cardioprotective effects reducing body weight This last effect led to the study and ultimate approval of some GLP-1 analogs as an obesity treatment
[DOI] [PubMed] [Google Scholar] 66.Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC)
Wegovy is a GLP-1 receptor agonist licensed by the MHRA for chronic weight management, whilst melatonin is a prescription-only medicine in the UK indicated for short-term treatment of primary insomnia in adults aged 55 and over